Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Mantle Cell Lymphoma Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Mantle Cell Lymphoma Treatment Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Acalabrutinib
    • 1.4.3 JCAR-017
    • 1.4.4 JNJ-64052781
    • 1.4.5 Acalisib
    • 1.4.6 IGN-002
    • 1.4.7 IMGN-529
    • 1.4.8 AFM-11
    • 1.4.9 Others
  • 1.5 Market by Application
    • 1.5.1 Global Mantle Cell Lymphoma Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Mantle Cell Lymphoma Treatment Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Mantle Cell Lymphoma Treatment Industry
      • 1.6.1.1 Mantle Cell Lymphoma Treatment Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Mantle Cell Lymphoma Treatment Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Mantle Cell Lymphoma Treatment Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Mantle Cell Lymphoma Treatment Market Perspective (2015-2026)
  • 2.2 Mantle Cell Lymphoma Treatment Growth Trends by Regions
    • 2.2.1 Mantle Cell Lymphoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Mantle Cell Lymphoma Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Mantle Cell Lymphoma Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Mantle Cell Lymphoma Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Mantle Cell Lymphoma Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Mantle Cell Lymphoma Treatment Players by Market Size
    • 3.1.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio
    • 3.2.1 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Treatment Revenue in 2019
  • 3.3 Mantle Cell Lymphoma Treatment Key Players Head office and Area Served
  • 3.4 Key Players Mantle Cell Lymphoma Treatment Product Solution and Service
  • 3.5 Date of Enter into Mantle Cell Lymphoma Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2021-2026)

5 Mantle Cell Lymphoma Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)
  • 5.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Mantle Cell Lymphoma Treatment Market Size (2015-2020)
  • 6.2 Mantle Cell Lymphoma Treatment Key Players in North America (2019-2020)
  • 6.3 North America Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
  • 6.4 North America Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Mantle Cell Lymphoma Treatment Market Size (2015-2020)
  • 7.2 Mantle Cell Lymphoma Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Mantle Cell Lymphoma Treatment Market Size (2015-2020)
  • 8.2 Mantle Cell Lymphoma Treatment Key Players in China (2019-2020)
  • 8.3 China Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
  • 8.4 China Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Mantle Cell Lymphoma Treatment Market Size (2015-2020)
  • 9.2 Mantle Cell Lymphoma Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Mantle Cell Lymphoma Treatment Market Size (2015-2020)
  • 10.2 Mantle Cell Lymphoma Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Mantle Cell Lymphoma Treatment Market Size (2015-2020)
  • 11.2 Mantle Cell Lymphoma Treatment Key Players in India (2019-2020)
  • 11.3 India Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
  • 11.4 India Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Mantle Cell Lymphoma Treatment Market Size (2015-2020)
  • 12.2 Mantle Cell Lymphoma Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Astex Pharmaceuticals, Inc.
    • 13.1.1 Astex Pharmaceuticals, Inc. Company Details
    • 13.1.2 Astex Pharmaceuticals, Inc. Business Overview and Its Total Revenue
    • 13.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Introduction
    • 13.1.4 Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020))
    • 13.1.5 Astex Pharmaceuticals, Inc. Recent Development
  • 13.2 Bayer AG
    • 13.2.1 Bayer AG Company Details
    • 13.2.2 Bayer AG Business Overview and Its Total Revenue
    • 13.2.3 Bayer AG Mantle Cell Lymphoma Treatment Introduction
    • 13.2.4 Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.2.5 Bayer AG Recent Development
  • 13.3 Bristol-Myers Squibb Company
    • 13.3.1 Bristol-Myers Squibb Company Company Details
    • 13.3.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
    • 13.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Introduction
    • 13.3.4 Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.3.5 Bristol-Myers Squibb Company Recent Development
  • 13.4 Celgene Corporation
    • 13.4.1 Celgene Corporation Company Details
    • 13.4.2 Celgene Corporation Business Overview and Its Total Revenue
    • 13.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Introduction
    • 13.4.4 Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.4.5 Celgene Corporation Recent Development
  • 13.5 Cellular Biomedicine Group, Inc.
    • 13.5.1 Cellular Biomedicine Group, Inc. Company Details
    • 13.5.2 Cellular Biomedicine Group, Inc. Business Overview and Its Total Revenue
    • 13.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Introduction
    • 13.5.4 Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.5.5 Cellular Biomedicine Group, Inc. Recent Development
  • 13.6 Eisai
    • 13.6.1 Eisai Company Details
    • 13.6.2 Eisai Business Overview and Its Total Revenue
    • 13.6.3 Eisai Mantle Cell Lymphoma Treatment Introduction
    • 13.6.4 Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.6.5 Eisai Recent Development
  • 13.7 EpiZyme, Inc.
    • 13.7.1 EpiZyme, Inc. Company Details
    • 13.7.2 EpiZyme, Inc. Business Overview and Its Total Revenue
    • 13.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Introduction
    • 13.7.4 EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.7.5 EpiZyme, Inc. Recent Development
  • 13.8 Fate Therapeutics, Inc.
    • 13.8.1 Fate Therapeutics, Inc. Company Details
    • 13.8.2 Fate Therapeutics, Inc. Business Overview and Its Total Revenue
    • 13.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Introduction
    • 13.8.4 Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.8.5 Fate Therapeutics, Inc. Recent Development
  • 13.9 Genentech, Inc.
    • 13.9.1 Genentech, Inc. Company Details
    • 13.9.2 Genentech, Inc. Business Overview and Its Total Revenue
    • 13.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Introduction
    • 13.9.4 Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.9.5 Genentech, Inc. Recent Development
  • 13.10 Gilead Sciences, Inc.
    • 13.10.1 Gilead Sciences, Inc. Company Details
    • 13.10.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue
    • 13.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Introduction
    • 13.10.4 Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 13.10.5 Gilead Sciences, Inc. Recent Development
  • 13.11 GlaxoSmithKline Plc
    • 10.11.1 GlaxoSmithKline Plc Company Details
    • 10.11.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
    • 10.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Introduction
    • 10.11.4 GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 10.11.5 GlaxoSmithKline Plc Recent Development
  • 13.12 Hutchison MediPharma Limited
    • 10.12.1 Hutchison MediPharma Limited Company Details
    • 10.12.2 Hutchison MediPharma Limited Business Overview and Its Total Revenue
    • 10.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Introduction
    • 10.12.4 Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 10.12.5 Hutchison MediPharma Limited Recent Development
  • 13.13 ImmunoGen, Inc.
    • 10.13.1 ImmunoGen, Inc. Company Details
    • 10.13.2 ImmunoGen, Inc. Business Overview and Its Total Revenue
    • 10.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Introduction
    • 10.13.4 ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 10.13.5 ImmunoGen, Inc. Recent Development
  • 13.14 Immunomedics, Inc.
    • 10.14.1 Immunomedics, Inc. Company Details
    • 10.14.2 Immunomedics, Inc. Business Overview and Its Total Revenue
    • 10.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Introduction
    • 10.14.4 Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
    • 10.14.5 Immunomedics, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Mantle Cell Lymphoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mantle Cell Lymphoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Astex Pharmaceuticals, Inc.
    Bayer AG
    Bristol-Myers Squibb Company
    Celgene Corporation
    Cellular Biomedicine Group, Inc.
    Eisai
    EpiZyme, Inc.
    Fate Therapeutics, Inc.
    Genentech, Inc.
    Gilead Sciences, Inc.
    GlaxoSmithKline Plc
    Hutchison MediPharma Limited
    ImmunoGen, Inc.
    Immunomedics, Inc.

    Market segment by Type, the product can be split into
    Acalabrutinib
    JCAR-017
    JNJ-64052781
    Acalisib
    IGN-002
    IMGN-529
    AFM-11
    Others
    Market segment by Application, split into
    Hospital
    Clinic
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Mantle Cell Lymphoma Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Mantle Cell Lymphoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Mantle Cell Lymphoma Treatment are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now